de Jonge Stijn W, Boldingh Quirine J J, Solomkin Joseph S, Allegranzi Benedetta, Egger Matthias, Dellinger E Patchen, Boermeester Marja A
1 Department of Surgery, Academic Medical Center Amsterdam , The Netherlands .
2 Department of Surgery, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Surg Infect (Larchmt). 2017 May/Jun;18(4):508-519. doi: 10.1089/sur.2016.272. Epub 2017 Apr 27.
Surgical site infections (SSIs) are one of the most common hospital-acquired infections. To reduce SSIs, prophylactic intra-operative wound irrigation (pIOWI) has been advocated, although the results to date are equivocal. To develop recommendations for the new World Health Organization (WHO) SSI prevention guidelines, a systematic literature review and a meta-analysis were conducted on the effectiveness of pIOWI using different agents as a means of reducing SSI.
The PUBMED, Embase, CENTRAL, CINAHL, and WHO databases were searched. Randomized controlled trials (RCTs) comparing either pIOWI with no pIOWI or with pIOWI using different solutions and techniques were retrieved with SSI as the primary outcome. Meta-analyses were performed, and odds ratios (OR) and the mean difference with 95% confidence intervals (CI) were extracted and pooled with a random effects model.
Twenty-one studies were suitable for analysis, and a distinction was made between intra-peritoneal, mediastinal, and incisional wound irrigation. A low quality of evidence demonstrated a statistically significant benefit for incisional wound irrigation with an aqueous povidone-iodine (PVP-I) solution in clean and clean contaminated wounds (OR 0.31; 95% CI 0.13-0.73; p = 0.007); 50 fewer SSIs per 1,000 procedures (from 19 fewer to 64 fewer)). Antibiotic irrigation had no significant effect in reducing SSIs (OR 1.16; 95% CI 0.64-2.12; p = 0.63).
Low-quality evidence suggests considering the use of prophylactic incisional wound irrigation to prevent SSI with an aqueous povidone-iodine solution. Antibiotic irrigation does not show a benefit and therefore is discouraged.
手术部位感染(SSIs)是最常见的医院获得性感染之一。为了减少手术部位感染,有人主张术中预防性伤口冲洗(pIOWI),尽管迄今为止的结果尚无定论。为制定新的世界卫生组织(WHO)手术部位感染预防指南,我们对使用不同药物进行术中预防性伤口冲洗作为减少手术部位感染手段的有效性进行了系统的文献综述和荟萃分析。
检索了PUBMED、Embase、CENTRAL、CINAHL和WHO数据库。纳入以手术部位感染作为主要结局,比较术中预防性伤口冲洗与不冲洗或使用不同溶液和技术进行术中预防性伤口冲洗的随机对照试验(RCTs)。进行荟萃分析,提取比值比(OR)和95%置信区间(CI)的平均差,并采用随机效应模型进行汇总。
21项研究适合分析,区分了腹腔内、纵隔和切口伤口冲洗。低质量证据表明,在清洁和清洁-污染伤口中,使用水性聚维酮碘(PVP-I)溶液进行切口伤口冲洗具有统计学意义的益处(OR 0.31;95%CI 0.13-0.73;p = 0.007);每1000例手术中手术部位感染减少50例(从减少19例到减少64例)。抗生素冲洗在减少手术部位感染方面没有显著效果(OR 1.16;95%CI 0.64-2.12;p = 0.63)。
低质量证据表明,可考虑使用预防性切口伤口冲洗,以预防水性聚维酮碘溶液导致的手术部位感染。抗生素冲洗未显示出益处,因此不建议使用。